Login

Watch CNBC's full interview with Orange CEO Christel Heydemann discussing telecommunications and technology trends. 00:10:00

Share On Facebook Share On Twitter

Xavier Pichon is Chief Executive Officer at Orange Belgium. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Eric's Journey from Product Management to Award-Winning CMO at Infinidat
00:10:00
500 million seed-stage venture firm that commits early|Jeff Clavier,Founder and Managing Partner,Uncork Capital
00:10:00
Global network and operational resources make us more valuable than capital alone|Reeta, Co-Founder,The Silverfern Group, Inc.
00:10:00
Raz Roditti on Razor Labs' DataMind AI Solution License Agreement | Raz Roditti, CEO , Razor Labs Ltd.
00:10:00
GAM and SHK & Co Announce Strategic Alliance to Drive Growth and Enhance Distribution in Greater China|Rob Mumford, Investment Manager,gam investments
00:10:00
BrandProjects team has partnered with seed stage founders supporting their efforts to build world class brands|Andrew Black,Managing Partner,BrandProject
00:10:00
Welcome to seat11a; in today's video, Till Giessmann, Head of Investor Relations at Energiekontor AG, will present his insights on the company's financial outlook and renewable energy projects.
00:10:00
PIC CEO Abel Reflects on Asset Growth, Market Recovery, and Social Impact Amidst Pandemic Turbulence | Abel Sithole, CEO , Public Investment Corporation.
00:10:00
Developing a portfolio of innovative products|James Barder,Chief Executive,Futura Medical
00:10:00
Zurich FinTech scene inside out and prophesies a great future for it|Andreas Iten,CEO, Co-Founder,SIX FinTech Ventures
00:10:00
Marcia Page: Pioneering Leader as Founder & CEO of MPowered Capital and Co-Founder of Värde Partners
00:10:00
"Gerard K. O'Reilly on the Evolution of Indexing and Factor-Based Investing: Insights into Dimensional Fund Advisors’ Evidence-Based Approach and Inclusion in Endowus CPF Portfolios"

© 2026 Nehu